Keyphrases
Phencyclidine
100%
Receptor Subtypes
100%
Nicotinic Acetylcholine Receptor (nAChR)
100%
Social Behavior
100%
Cognitive Behavior
100%
Habitual Smoking
42%
Behavioral Sensitization
28%
Schizophrenia
28%
Attenuating Effect
28%
Behavioral Impairment
28%
Conditioned Place Preference
28%
Psychological Dependence
28%
Prefrontal Cortex
14%
Psychosis
14%
Central Nervous System
14%
Patients with Schizophrenia
14%
Risperidone
14%
Nucleus Accumbens
14%
Nicotine
14%
Vulnerability
14%
Decreased Expression
14%
Effective Dose
14%
Repeated Administration
14%
Therapeutic Effect
14%
Synergistic Effect
14%
α7 Nicotinic Acetylcholine Receptor (α7nAChR)
14%
Haloperidol-induced Catalepsy
14%
Neuroscience
Dementia Praecox
100%
Behavior (Neuroscience)
100%
Phencyclidine
100%
Nicotinic Acetylcholine Receptor
100%
Receptor Subtype
100%
Conditioned Place Preference
66%
Prefrontal Cortex
33%
Central Nervous System
33%
Risperidone
33%
Nucleus Accumbens
33%
Haloperidol-Induced Catalepsy
33%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse
100%
Phencyclidine
100%
Nicotinic Receptor
100%
Receptor Subtype
100%
Mouse Model
16%
Side Effect
16%
Therapeutic Effect
16%
Risperidone
16%
Haloperidol-Induced Catalepsy
16%